Anthem Biosciences Ltd
BSE: 544449
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 582.50+39.8% | 416.57-24.6% | 552.23+2.6% | 538.01 |
| Other Income | 60.63+51.9% | 39.92-25.8% | 53.80+94.0% | 27.73 |
| Total Income | 643.13+40.9% | 456.50-24.7% | 606.02+7.1% | 565.74 |
| EXPENSES | ||||
| Expenditure | 343.38+22.0% | 281.40-20.2% | 352.72-3.8% | 366.80 |
| Tax | 89.06+134.5% | 37.98-30.8% | 54.87+8.4% | 50.60 |
| PROFIT | ||||
| PBT | 300.72+100.3% | 150.11-40.7% | 253.30+27.3% | 198.94 |
| Net Profit | 211.66+88.8% | 112.12-43.5% | 198.43+33.8% | 148.34 |
| KEY METRICS | ||||
| OPM % | 46.00%+12.86pp | 33.14%-7.72pp | 40.86%+4.54pp | 36.32% |
| NPM % | 32.91%+8.35pp | 24.56%-8.18pp | 32.74%+6.52pp | 26.22% |
| EPS | 3.77+88.5% | 2.00-43.5% | 3.54+33.6% | 2.65 |